Source: Atherosclerosis. Unidade: FM
Subjects: APOLIPOPROTEÍNAS, COLESTEROL, LIPOPROTEÍNAS HDL, MEIA IDADE, FOSFOLIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZHENG, Kang H et al. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, v. 311, p. 13-19, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2020.08.004. Acesso em: 16 nov. 2024.APA
Zheng, K. H., Kaiser, Y., Olden, C. C. van, Santos Filho, R. D. dos, Dasseux, J. -L., Genest, J., et al. (2020). No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels. Atherosclerosis, 311, 13-19. doi:10.1016/j.atherosclerosis.2020.08.004NLM
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004Vancouver
Zheng KH, Kaiser Y, Olden CC van, Santos Filho RD dos, Dasseux J-L, Genest J, Gaudet D, Westerink J, Verberne HJ. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels [Internet]. Atherosclerosis. 2020 ; 311 13-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2020.08.004